These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 13466954)

  • 1. [Psychopathological experiences with the combined action of lysergic acid mono- & diethylamide (LAE-32, LSD-25)].
    CALLIERI B; RAVETTA M
    Riv Sper Freniatr Med Leg Alien Ment; 1957 Jul; 81(2):267-313. PubMed ID: 13466954
    [No Abstract]   [Full Text] [Related]  

  • 2. [Effect of monoethylamide (LAE) and diethylamide (LSD) of lysergic acid on behavior of mouse with imino-beta, beta-dipropionitrile induced circular movement].
    WIDLOCHER D; NAKAJIMA H; THUILLIER J
    C R Seances Soc Biol Fil; 1957; 151(4):668-70. PubMed ID: 13489946
    [No Abstract]   [Full Text] [Related]  

  • 3. Lysergic acid diethylamide (LSD-25) antagonists. II. Development of tolerance in man to LSD-25 by prior administration of MLD-41 (1-methyl-d-lysergic acid diethylamide).
    ABRAMSON HA; SKLAROFSKY B; BARON MO; FREMONT-SMITH N
    AMA Arch Neurol Psychiatry; 1958 Feb; 79(2):201-7. PubMed ID: 13497364
    [No Abstract]   [Full Text] [Related]  

  • 4. [Study of the antagonistic psychopathological effects of lysergic acid monoethylamide (LAE-32) & methylphenylisopropylamine (pervitin)].
    CALLIERI B; RAVETTA M
    Rass Neuropsichiatr; 1957; 11(3-4):198-216. PubMed ID: 13506109
    [No Abstract]   [Full Text] [Related]  

  • 5. Pharmacopsychiatric study on a case of obsessive psychoneurosis; obsessive states during use of sympathomimetic drugs, amphetamine, LSD 25 & LAE 32.
    GIBERTI F; BREGORETTI L
    Sist Nerv; 1957; 9(4):275-88. PubMed ID: 13495598
    [No Abstract]   [Full Text] [Related]  

  • 6. [Experiences with lysergic acid diethylamide (LSD 25)].
    GUEDES PL
    Arq Neuropsiquiatr; 1961 Mar; 19():28-34. PubMed ID: 13709401
    [No Abstract]   [Full Text] [Related]  

  • 7. Lysergic acid diethylamide (LSD-25). XXXI. Comparison by questionnaire of psychotomimetic activity of congeners on normal subjects and drug addicts.
    ABRAMSON HA
    J Ment Sci; 1960 Jul; 106():1120-3. PubMed ID: 13681136
    [No Abstract]   [Full Text] [Related]  

  • 8. [From LSD to self-hypnosis in "psychedelic" experiences, art and therapy].
    Grüholz G
    Z Klin Psychol Psychother; 1971; 19():34-41. PubMed ID: 5162525
    [No Abstract]   [Full Text] [Related]  

  • 9. [Protective action of lysergic acid ethylamide (LAE-32) on behavior changes & on histological lesions of the central nervous system induced in mice by chronic treatment with 5-hydroxytryptamine].
    SORIANI S; FAVALE E
    Sist Nerv; 1959; 11(1):13-21. PubMed ID: 13659105
    [No Abstract]   [Full Text] [Related]  

  • 10. [LSD treatment. Psychotherapy with the aid of lysergic acid diethylamide].
    ANDERSEN H; KRISTENSEN KK; KNUDSEN KP
    Ugeskr Laeger; 1961 Oct; 123():1449-52. PubMed ID: 13861164
    [No Abstract]   [Full Text] [Related]  

  • 11. [Therapeutic use of LSD 25 in clinical psychiatry].
    JOST F
    Wien Klin Wochenschr; 1957 Sep; 96(36):647-51. PubMed ID: 13468477
    [No Abstract]   [Full Text] [Related]  

  • 12. Studies on the diethylamide of lysergic acid (LSD-25). II. Effects of chlorpromazine, azacyclonol, and reserpine on the intensity of the LSD-reaction.
    ISBELL H; LOGAN CR
    AMA Arch Neurol Psychiatry; 1957 Apr; 77(4):350-8. PubMed ID: 13410191
    [No Abstract]   [Full Text] [Related]  

  • 13. [The double aspect of LSD].
    Monnerot-Dumaine
    Presse Med (1893); 1967 Sep; 75(37):1857-8. PubMed ID: 6053120
    [No Abstract]   [Full Text] [Related]  

  • 14. [Our experience with the treatment of mental patients with lysergic acid diethylamine (LSD-25)].
    JOVANOVIC D; KANDIC B; KRONJA T
    Vopr Virusol; 1960; 5():251-6. PubMed ID: 14408013
    [No Abstract]   [Full Text] [Related]  

  • 15. [Pharmacotherapy and psychotherapy. LSD as an adjuvant in psychotherapy?].
    Booij J
    Ned Tijdschr Geneeskd; 1968 Jan; 112(1):2-7. PubMed ID: 5691284
    [No Abstract]   [Full Text] [Related]  

  • 16. Verbatim recording and transference studies with lysergic acid diethylamide (LSD-25).
    ABRAMSON HA
    J Nerv Ment Dis; 1957; 125(3):444-50. PubMed ID: 13481754
    [No Abstract]   [Full Text] [Related]  

  • 17. [Lysergic acid diethylamide (LSD-25) test and psychotropic therapy: electroencephalographic study].
    Borenstein P; Cujo P; Olivenstein C
    Ann Med Psychol (Paris); 1965 Jul; 123(2):237-46. PubMed ID: 5852791
    [No Abstract]   [Full Text] [Related]  

  • 18. [Psycholytic interval therapy with LSD 25 or ambulant psychoanalytical therapy?].
    Derbolowsky U
    Z Psychother Med Psychol; 1966 Jan; 16(1):33-8. PubMed ID: 5911900
    [No Abstract]   [Full Text] [Related]  

  • 19. Elucidation of LSD in vitro metabolism by liquid chromatography and capillary electrophoresis coupled with tandem mass spectrometry.
    Cai J; Henion J
    J Anal Toxicol; 1996; 20(1):27-37. PubMed ID: 8837948
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Relationships of psychotomimetic to anti-serotonin potencies of congeners of lysergic acid diethylamide (LSD-25).
    ISBELL H; MINER EJ; LOGAN CR
    Psychopharmacologia; 1959; 1():20-8. PubMed ID: 14405872
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.